Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PeptiDream | Tokyo | Healthcare | Biotechnology & Medical Research | ¥295B | 19.6x | 0.05 | ¥2,276 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GNI | Tokyo | Healthcare | Biotechnology & Medical Research | ¥127.39B | 129.3x | -1.47 | ¥2,540 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Takara Bio | Tokyo | Healthcare | Biotechnology & Medical Research | ¥101.27B | -1,940x | 18.85 | ¥841 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.9% Upside | Upgrade to Pro+ | |
Sanbio Company | Tokyo | Healthcare | Biotechnology & Medical Research | ¥81.78B | -26.7x | -0.54 | ¥1,153 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -13.3% Downside | Upgrade to Pro+ | |
Shin Nippon Biomed Lab | Tokyo | Healthcare | Biotechnology & Medical Research | ¥64.07B | 13x | -1.27 | ¥1,539 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Heartseed | Tokyo | Healthcare | Biotechnology & Medical Research | ¥44.89B | -35.8x | -1.03 | ¥2,009 | 14.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Healios K K | Tokyo | Healthcare | Biotechnology & Medical Research | ¥27.24B | -5.8x | -0.43 | ¥277 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.8% Upside | Upgrade to Pro+ | |
Pharma Foods | Tokyo | Healthcare | Biotechnology & Medical Research | ¥25.35B | 9.6x | -0.22 | ¥904 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AnGes | Tokyo | Healthcare | Biotechnology & Medical Research | ¥20.12B | -0.6x | 0 | ¥66 | 4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chordia Therapeutics | Tokyo | Healthcare | Biotechnology & Medical Research | ¥17.46B | -9.6x | 0.01 | ¥256 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
3-D Matrix | Tokyo | Healthcare | Biotechnology & Medical Research | ¥14.78B | -13.1x | -0.48 | ¥136 | -14.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MediciNova | Tokyo | Healthcare | Biotechnology & Medical Research | ¥11.3B | -6.8x | 0.24 | ¥231 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NanoCarrier | Tokyo | Healthcare | Biotechnology & Medical Research | ¥11.23B | -17.4x | -0.45 | ¥159 | 10.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chiome Bioscience | Tokyo | Healthcare | Biotechnology & Medical Research | ¥10.51B | -8.9x | -0.36 | ¥156 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PRISM BioLab | Tokyo | Healthcare | Biotechnology & Medical Research | ¥10.21B | ¥284 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Tsubota Laboratory | Tokyo | Healthcare | Biotechnology & Medical Research | ¥9.87B | 28.6x | 0.18 | ¥385 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medinet | Tokyo | Healthcare | Biotechnology & Medical Research | ¥9.26B | -1.4x | ¥35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Cyfuse Biomedical KK | Tokyo | Healthcare | Biotechnology & Medical Research | ¥8.92B | -8.5x | 0.23 | ¥1,130 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TMS | Tokyo | Healthcare | Biotechnology & Medical Research | ¥8.31B | -7.4x | 0.16 | ¥206 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Linical Co Ltd | Tokyo | Healthcare | Biotechnology & Medical Research | ¥7.57B | -32.5x | 0.24 | ¥335 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.3% Upside | Upgrade to Pro+ | |
NoileImmune Biotech | Tokyo | Healthcare | Biotechnology & Medical Research | ¥7.45B | -8.3x | -0.42 | ¥172 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DNA Chip Research | Tokyo | Healthcare | Biotechnology & Medical Research | ¥7.41B | -208.6x | -2.4 | ¥1,095 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OncoTherapy | Tokyo | Healthcare | Biotechnology & Medical Research | ¥7.06B | -6.3x | -0.24 | ¥26 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Modalis | Tokyo | Healthcare | Biotechnology & Medical Research | ¥6.4B | -3.5x | -0.08 | ¥88 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kidswell Bio | Tokyo | Healthcare | Biotechnology & Medical Research | ¥5.57B | -7.8x | ¥137 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kringle | Tokyo | Healthcare | Biotechnology & Medical Research | ¥5.57B | -6.4x | -0.29 | ¥814 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Veritas In Silico | Tokyo | Healthcare | Biotechnology & Medical Research | ¥5.44B | -23.9x | 0.03 | ¥838 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carna Biosciences | Tokyo | Healthcare | Biotechnology & Medical Research | ¥5.39B | -2.3x | 0.03 | ¥282 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ribomic | Tokyo | Healthcare | Biotechnology & Medical Research | ¥5.31B | -4.7x | -0.64 | ¥119 | 5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
D.Western Therapeutics Institute | Tokyo | Healthcare | Biotechnology & Medical Research | ¥5.05B | -3.2x | 0.09 | ¥118 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Human Metabolome Tech | Tokyo | Healthcare | Biotechnology & Medical Research | ¥4.12B | 15.5x | -2.53 | ¥696 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Funpep | Tokyo | Healthcare | Biotechnology & Medical Research | ¥4.12B | -4.1x | -0.24 | ¥127 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BrightPath Biotherapeutics | Tokyo | Healthcare | Biotechnology & Medical Research | ¥3.78B | -1x | ¥43 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
PhoenixBio Co | Tokyo | Healthcare | Biotechnology & Medical Research | ¥1.55B | -11.2x | 0.05 | ¥382 | -5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |